Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rotem Erez

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|July 18, 2008
The azaquinone-methide elimination: comparison study of 1,6- and 1,4-eliminations under physiological conditionsRotem Erez, Doron Shabat
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activationRotem Erez, Sharon Ebner, Bernard Attali, et al.
Bioorganic & Medicinal Chemistry|June 2, 2009
Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxelRotem Erez, Ehud Segal, Keren Miller, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2009
Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugateKeren Miller, Rotem Erez, Ehud Segal, et al.
Chemical Communications (Cambridge, England)|August 18, 2010
Sulfhydryl-based dendritic chain reactionEran Sella, Roy Weinstain, Rotem Erez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|July 18, 2008
The azaquinone-methide elimination: comparison study of 1,6- and 1,4-eliminations under physiological conditionsRotem Erez, Doron Shabat
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activationRotem Erez, Sharon Ebner, Bernard Attali, et al.
Bioorganic & Medicinal Chemistry|June 2, 2009
Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxelRotem Erez, Ehud Segal, Keren Miller, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2009
Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugateKeren Miller, Rotem Erez, Ehud Segal, et al.
Chemical Communications (Cambridge, England)|August 18, 2010
Sulfhydryl-based dendritic chain reactionEran Sella, Roy Weinstain, Rotem Erez, et al.
Pageof 1